Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7X8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,949
Award facts
- Contract value 100% obligated
- $45,948.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,948.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on January 21, 2026, with a completion date of January 22, 2026. This non-competitive delivery order was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order falls within the broader context of federal pharmaceutical procurement to support military treatment facilities and defense healthcare systems. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of prescription drugs, specialty medications, and medical supplies delivered across multiple therapeutic domains. As a major pharmaceutical distributor, AmerisourceBergen maintains critical vendor status for federal medical procurement and has demonstrated capability to meet government requirements through open and competitive procurement processes. The firm fixed-price structure and expedited completion timeline reflect typical DLA medical supply chain procurement practices for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FV7X8?
SPE2DR26FV7X8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV7X8 worth?
The government has obligated $45,949 on SPE2DR26FV7X8.
Is contract SPE2DR26FV7X8 an order under another contract?
Yes. SPE2DR26FV7X8 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7X8 competed?
The extent of competition for SPE2DR26FV7X8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award